XML 46 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-based Compensation Plans (Tables)
12 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation Expenses Stock-based compensation expense was reported as follows on the consolidated statements of operations:

 

Fiscal Year

 

(In thousands)

2023

 

 

2022

 

 

2021

 

Product costs

$

279

 

 

$

234

 

 

$

122

 

Research and development

 

1,417

 

 

 

1,424

 

 

 

1,298

 

Selling, general and administrative

 

5,909

 

 

 

5,399

 

 

 

4,443

 

Total stock-based compensation expense

$

7,605

 

 

$

7,057

 

 

$

5,863

 

Stock Option Fair Value Assumptions and Weighted Average Grant Date Fair Value of Stock Options Granted stock option fair value assumptions and the weighted average grant date fair value of stock options granted were as follows:

 

Fiscal Year

 

 

2023

 

 

2022

 

 

2021

 

Stock option fair value assumptions:

 

 

 

 

 

 

 

 

Risk-free interest rate

 

3.76

%

 

 

1.49

%

 

 

0.40

%

Expected life (years)

4.7

 

 

4.6

 

 

4.6

 

Expected volatility

 

45

%

 

 

43

%

 

 

43

%

Dividend yield

 

%

 

 

%

 

 

%

Weighted average grant date fair value of stock options granted

$

15.03

 

 

$

15.96

 

 

$

14.71

 

Schedule of Stock Option Activity

Stock option activity was as follows:

(In thousands, except per share data)

Number of
Shares

 

 

Weighted
Average
Exercise Price

 

Options outstanding at September 30, 2020

 

940

 

 

$

35.18

 

Granted

 

274

 

 

 

40.95

 

Exercised

 

(248

)

 

 

24.22

 

Forfeited and expired

 

(44

)

 

 

44.58

 

Options outstanding at September 30, 2021

 

922

 

 

 

39.39

 

Granted

 

342

 

 

 

42.10

 

Exercised

 

(45

)

 

 

21.24

 

Forfeited and expired

 

(58

)

 

 

43.99

 

Options outstanding at September 30, 2022

 

1,161

 

 

 

40.66

 

Granted

 

311

 

 

 

34.73

 

Exercised

 

(20

)

 

 

21.50

 

Forfeited and expired

 

(90

)

 

 

41.77

 

Options outstanding at September 30, 2023

 

1,362

 

 

 

39.52

 

Options vested and exercisable at September 30, 2023

 

724

 

 

$

40.47

 

 

Schedule of Restricted Stock Activity

Restricted Stock activity was as follows:

(In thousands, except per share data)

Number of
Shares

 

 

Weighted Average
Grant Date
Fair Value

 

Unvested restricted stock awards at September 30, 2020

 

100

 

 

$

44.16

 

Granted

 

71

 

 

 

38.83

 

Vested

 

(48

)

 

 

44.07

 

Forfeited

 

(4

)

 

 

40.45

 

Unvested restricted stock awards at September 30, 2021

 

119

 

 

 

41.14

 

Granted

 

99

 

 

 

42.35

 

Vested

 

(55

)

 

 

42.98

 

Forfeited

 

(5

)

 

 

41.83

 

Unvested restricted stock awards at September 30, 2022

 

158

 

 

 

41.24

 

Granted

 

103

 

 

 

35.75

 

Vested

 

(69

)

 

 

40.96

 

Forfeited

 

(19

)

 

 

39.31

 

Unvested restricted stock awards at September 30, 2023

 

173

 

 

$

38.30